The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer
- PMID: 29666818
- PMCID: PMC5890043
- DOI: 10.21037/atm.2018.01.25
The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer
Abstract
Lung cancer is a common disease and the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following diagnosis of lung cancer, accurate staging is essential to guide clinical management and inform prognosis. Positron emission tomography (PET) in conjunction with computed tomography (CT)-as PET-CT has developed as an important tool in the multi-disciplinary management of lung cancer. This article will review the current evidence for the role of 18F-fluorodeoxyglucose (FDG) PET-CT in NSCLC diagnosis, staging, response assessment and follow up.
Keywords: Positron emission tomography (PET); diagnosis; follow up; non-small cell lung cancer (NSCLC); response assessment; staging.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources